Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by wildbird1on Nov 14, 2023 11:23am
441 Views
Post# 35734448

0.17$ versus 0.22$(+ warrant).

0.17$ versus 0.22$(+ warrant).Many peoples on this board pretend that a newcomer is better off buying at 0.17$ instead of 0.22$(+warrant).

Let's assume that a newcomer has done his DD and came to the conclusion that TLT-Ruvidar has a huge potential.
This newcomer want 100k TLT shares but has only $11,000 available.

Option 1) 65,000K shares X 0.17$ = $11,000

Option 2) 50K shares X 0.22$(+1warrants) = $11,000
50Kshares + 1 warrant =100K tlt shares.
I did not factor in the warrants at 0.28$, because the newcomer didn't pay for these warrants(yet), but these warrants are his property should he choose to exercise.

EX: If after TLT get the final approval and get to commercialisation the SP climb to $10.00, this newcomer will have done $1 million - $25,000($11,000 + $14,000(cost of warrants at 0.28$)) for a total of $975K profit with an initial investment of $11,000.

Option 1) at 0.17$ did only $640K profit.
Option 2) at 0.22$(+warrants) did a $975K profit.

In short yes, buying at 0.22$shares(+warrants) is profitable.




<< Previous
Bullboard Posts
Next >>